FDA Safety Plan Is Only First Step, But Agency Says No New Authority Needed
This article was originally published in The Tan Sheet
FDA's description of its plan to improve oversight of drug safety acknowledges the agency's efforts are part of an ongoing process - but not necessarily one needing outside involvement
You may also be interested in...
FDA is modifying the charter for its Risk Communication Advisory Committee to reflect new powers the agency gained as part of the passed FDA reauthorization bill
Senior FDA officials will have final say over drug safety disputes under proposed legislation from Sens. Michael Enzi (R-Wyo.) and Edward Kennedy (D-Mass.)
A Government Accountability Office report on drug safety recommends giving FDA the power to mandate postmarketing drug studies